▶ 調査レポート

世界の先天性心疾患治療装置市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Congenital Heart Disease Treatment Device Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の先天性心疾患治療装置市場 2021:企業別、地域別、種類・用途別 / Global Congenital Heart Disease Treatment Device Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-202A2397資料のイメージです。• レポートコード:GIR-202A2397
• 出版社/出版日:GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、87ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、先天性心疾患治療装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。先天性心疾患治療装置の種類別市場規模(人工心臓弁、ブラケット、補助人工心臓(VAD)、その他)、用途別市場規模(大人、子供)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・先天性心疾患治療装置の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Abbott、Medtronic plc、Beijing Balance Medical Technology、Med-Zenith、MicroPort、Weigao Holding Company Limited、CryoLife、Edwards LifeSciences
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:人工心臓弁、ブラケット、補助人工心臓(VAD)、その他
・用途別分析2016年-2026年:大人、子供
・先天性心疾患治療装置の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・先天性心疾患治療装置のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・先天性心疾患治療装置のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・先天性心疾患治療装置の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・先天性心疾患治療装置の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Congenital Heart Disease Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Congenital Heart Disease Treatment Device size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Congenital Heart Disease Treatment Device market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Congenital Heart Disease Treatment Device market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Artificial Heart Valve
Bracket
Ventricular Assist Device (VAD)
Other

Market segment by Application can be divided into
Adult
Children

The key market players for global Congenital Heart Disease Treatment Device market are listed below:
Abbott
Medtronic plc
Beijing Balance Medical Technology
Med-Zenith
MicroPort
Weigao Holding Company Limited
CryoLife
Edwards LifeSciences

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Congenital Heart Disease Treatment Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Congenital Heart Disease Treatment Device, with price, sales, revenue and global market share of Congenital Heart Disease Treatment Device from 2019 to 2021.
Chapter 3, the Congenital Heart Disease Treatment Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Congenital Heart Disease Treatment Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Congenital Heart Disease Treatment Device market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Congenital Heart Disease Treatment Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Congenital Heart Disease Treatment Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Congenital Heart Disease Treatment Device Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Artificial Heart Valve
1.2.3 Bracket
1.2.4 Ventricular Assist Device (VAD)
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Congenital Heart Disease Treatment Device Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Children
1.4 Global Congenital Heart Disease Treatment Device Market Size & Forecast
1.4.1 Global Congenital Heart Disease Treatment Device Sales in Value (2016-2026))
1.4.2 Global Congenital Heart Disease Treatment Device Sales in Volume (2016-2026)
1.4.3 Global Congenital Heart Disease Treatment Device Price by Type (2016-2026) & (US$/Unit)
1.5 Global Congenital Heart Disease Treatment Device Production Capacity Analysis
1.5.1 Global Congenital Heart Disease Treatment Device Total Production Capacity (2016-2026)
1.5.2 Global Congenital Heart Disease Treatment Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Congenital Heart Disease Treatment Device Market Drivers
1.6.2 Congenital Heart Disease Treatment Device Market Restraints
1.6.3 Congenital Heart Disease Treatment Device Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Congenital Heart Disease Treatment Device Product and Services
2.1.4 Abbott Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Medtronic plc
2.2.1 Medtronic plc Details
2.2.2 Medtronic plc Major Business
2.2.3 Medtronic plc Congenital Heart Disease Treatment Device Product and Services
2.2.4 Medtronic plc Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Beijing Balance Medical Technology
2.3.1 Beijing Balance Medical Technology Details
2.3.2 Beijing Balance Medical Technology Major Business
2.3.3 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product and Services
2.3.4 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Med-Zenith
2.4.1 Med-Zenith Details
2.4.2 Med-Zenith Major Business
2.4.3 Med-Zenith Congenital Heart Disease Treatment Device Product and Services
2.4.4 Med-Zenith Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 MicroPort
2.5.1 MicroPort Details
2.5.2 MicroPort Major Business
2.5.3 MicroPort Congenital Heart Disease Treatment Device Product and Services
2.5.4 MicroPort Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Weigao Holding Company Limited
2.6.1 Weigao Holding Company Limited Details
2.6.2 Weigao Holding Company Limited Major Business
2.6.3 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product and Services
2.6.4 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 CryoLife
2.7.1 CryoLife Details
2.7.2 CryoLife Major Business
2.7.3 CryoLife Congenital Heart Disease Treatment Device Product and Services
2.7.4 CryoLife Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Edwards LifeSciences
2.8.1 Edwards LifeSciences Details
2.8.2 Edwards LifeSciences Major Business
2.8.3 Edwards LifeSciences Congenital Heart Disease Treatment Device Product and Services
2.8.4 Edwards LifeSciences Congenital Heart Disease Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Congenital Heart Disease Treatment Device Sales by Manufacturer
3.1 Global Congenital Heart Disease Treatment Device Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Congenital Heart Disease Treatment Device Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Congenital Heart Disease Treatment Device
3.4 Market Concentration Rate
3.4.1 Top 3 Congenital Heart Disease Treatment Device Manufacturer Market Share
3.4.2 Top 6 Congenital Heart Disease Treatment Device Manufacturer Market Share
3.5 Global Congenital Heart Disease Treatment Device Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Congenital Heart Disease Treatment Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Congenital Heart Disease Treatment Device Market Size by Region
4.1.1 Global Congenital Heart Disease Treatment Device Sales in Volume by Region (2016-2026)
4.1.2 Global Congenital Heart Disease Treatment Device Revenue by Region (2016-2026)
4.2 North America Congenital Heart Disease Treatment Device Revenue (2016-2026)
4.3 Europe Congenital Heart Disease Treatment Device Revenue (2016-2026)
4.4 Asia-Pacific Congenital Heart Disease Treatment Device Revenue (2016-2026)
4.5 South America Congenital Heart Disease Treatment Device Revenue (2016-2026)
4.6 Middle East and Africa Congenital Heart Disease Treatment Device Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Congenital Heart Disease Treatment Device Sales in Volume by Type (2016-2026)
5.2 Global Congenital Heart Disease Treatment Device Revenue by Type (2016-2026)
5.3 Global Congenital Heart Disease Treatment Device Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Congenital Heart Disease Treatment Device Sales in Volume by Application (2016-2026)
6.2 Global Congenital Heart Disease Treatment Device Revenue by Application (2016-2026)
6.3 Global Congenital Heart Disease Treatment Device Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Congenital Heart Disease Treatment Device Sales by Type (2016-2026)
7.2 North America Congenital Heart Disease Treatment Device Sales by Application (2016-2026)
7.3 North America Congenital Heart Disease Treatment Device Market Size by Country
7.3.1 North America Congenital Heart Disease Treatment Device Sales in Volume by Country (2016-2026)
7.3.2 North America Congenital Heart Disease Treatment Device Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Congenital Heart Disease Treatment Device Sales by Type (2016-2026)
8.2 Europe Congenital Heart Disease Treatment Device Sales by Application (2016-2026)
8.3 Europe Congenital Heart Disease Treatment Device Market Size by Country
8.3.1 Europe Congenital Heart Disease Treatment Device Sales in Volume by Country (2016-2026)
8.3.2 Europe Congenital Heart Disease Treatment Device Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Congenital Heart Disease Treatment Device Sales by Type (2016-2026)
9.2 Asia-Pacific Congenital Heart Disease Treatment Device Sales by Application (2016-2026)
9.3 Asia-Pacific Congenital Heart Disease Treatment Device Market Size by Region
9.3.1 Asia-Pacific Congenital Heart Disease Treatment Device Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Congenital Heart Disease Treatment Device Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Congenital Heart Disease Treatment Device Sales by Type (2016-2026)
10.2 South America Congenital Heart Disease Treatment Device Sales by Application (2016-2026)
10.3 South America Congenital Heart Disease Treatment Device Market Size by Country
10.3.1 South America Congenital Heart Disease Treatment Device Sales in Volume by Country (2016-2026)
10.3.2 South America Congenital Heart Disease Treatment Device Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Congenital Heart Disease Treatment Device Sales by Type (2016-2026)
11.2 Middle East & Africa Congenital Heart Disease Treatment Device Sales by Application (2016-2026)
11.3 Middle East & Africa Congenital Heart Disease Treatment Device Market Size by Country
11.3.1 Middle East & Africa Congenital Heart Disease Treatment Device Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Congenital Heart Disease Treatment Device Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Congenital Heart Disease Treatment Device Typical Distributors
12.3 Congenital Heart Disease Treatment Device Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Congenital Heart Disease Treatment Device Revenue by Type, (USD Million), 2021-2026
Table 2. Global Congenital Heart Disease Treatment Device Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Congenital Heart Disease Treatment Device Product and Services
Table 6. Abbott Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic plc Major Business
Table 9. Medtronic plc Congenital Heart Disease Treatment Device Product and Services
Table 10. Medtronic plc Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Beijing Balance Medical Technology Basic Information, Manufacturing Base and Competitors
Table 12. Beijing Balance Medical Technology Major Business
Table 13. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product and Services
Table 14. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Med-Zenith Basic Information, Manufacturing Base and Competitors
Table 16. Med-Zenith Major Business
Table 17. Med-Zenith Congenital Heart Disease Treatment Device Product and Services
Table 18. Med-Zenith Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. MicroPort Basic Information, Manufacturing Base and Competitors
Table 20. MicroPort Major Business
Table 21. MicroPort Congenital Heart Disease Treatment Device Product and Services
Table 22. MicroPort Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Weigao Holding Company Limited Basic Information, Manufacturing Base and Competitors
Table 24. Weigao Holding Company Limited Major Business
Table 25. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product and Services
Table 26. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CryoLife Basic Information, Manufacturing Base and Competitors
Table 28. CryoLife Major Business
Table 29. CryoLife Congenital Heart Disease Treatment Device Product and Services
Table 30. CryoLife Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Edwards LifeSciences Basic Information, Manufacturing Base and Competitors
Table 32. Edwards LifeSciences Major Business
Table 33. Edwards LifeSciences Congenital Heart Disease Treatment Device Product and Services
Table 34. Edwards LifeSciences Congenital Heart Disease Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Congenital Heart Disease Treatment Device Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Congenital Heart Disease Treatment Device Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Congenital Heart Disease Treatment Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Congenital Heart Disease Treatment Device Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Congenital Heart Disease Treatment Device Production Site of Key Manufacturer
Table 40. Congenital Heart Disease Treatment Device New Entrant and Capacity Expansion Plans
Table 41. Congenital Heart Disease Treatment Device Mergers & Acquisitions in the Past Five Years
Table 42. Global Congenital Heart Disease Treatment Device Sales by Region (2016-2021e) & (K Units)
Table 43. Global Congenital Heart Disease Treatment Device Sales by Region (2021-2026) & (K Units)
Table 44. Global Congenital Heart Disease Treatment Device Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Congenital Heart Disease Treatment Device Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Congenital Heart Disease Treatment Device Sales by Type (2016-2021e) & (K Units)
Table 47. Global Congenital Heart Disease Treatment Device Sales by Type (2021-2026) & (K Units)
Table 48. Global Congenital Heart Disease Treatment Device Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Congenital Heart Disease Treatment Device Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Congenital Heart Disease Treatment Device Price by Type (2016-2021e) & (US$/Unit)
Table 51. Global Congenital Heart Disease Treatment Device Price by Type (2021-2026) & (US$/Unit)
Table 52. Global Congenital Heart Disease Treatment Device Sales by Application (2016-2021e) & (K Units)
Table 53. Global Congenital Heart Disease Treatment Device Sales by Application (2021-2026) & (K Units)
Table 54. Global Congenital Heart Disease Treatment Device Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Congenital Heart Disease Treatment Device Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Congenital Heart Disease Treatment Device Price by Application (2016-2021e) & (US$/Unit)
Table 57. Global Congenital Heart Disease Treatment Device Price by Application (2021-2026) & (US$/Unit)
Table 58. North America Congenital Heart Disease Treatment Device Sales by Country (2016-2021e) & (K Units)
Table 59. North America Congenital Heart Disease Treatment Device Sales by Country (2021-2026) & (K Units)
Table 60. North America Congenital Heart Disease Treatment Device Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Congenital Heart Disease Treatment Device Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Congenital Heart Disease Treatment Device Sales by Type (2016-2021e) & (K Units)
Table 63. North America Congenital Heart Disease Treatment Device Sales by Type (2021-2026) & (K Units)
Table 64. North America Congenital Heart Disease Treatment Device Sales by Application (2016-2021e) & (K Units)
Table 65. North America Congenital Heart Disease Treatment Device Sales by Application (2021-2026) & (K Units)
Table 66. Europe Congenital Heart Disease Treatment Device Sales by Country (2016-2021e) & (K Units)
Table 67. Europe Congenital Heart Disease Treatment Device Sales by Country (2021-2026) & (K Units)
Table 68. Europe Congenital Heart Disease Treatment Device Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Congenital Heart Disease Treatment Device Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Congenital Heart Disease Treatment Device Sales by Type (2016-2021e) & (K Units)
Table 71. Europe Congenital Heart Disease Treatment Device Sales by Type (2021-2026) & (K Units)
Table 72. Europe Congenital Heart Disease Treatment Device Sales by Application (2016-2021e) & (K Units)
Table 73. Europe Congenital Heart Disease Treatment Device Sales by Application (2021-2026) & (K Units)
Table 74. Asia-Pacific Congenital Heart Disease Treatment Device Sales by Region (2016-2021e) & (K Units)
Table 75. Asia-Pacific Congenital Heart Disease Treatment Device Sales by Region (2021-2026) & (K Units)
Table 76. Asia-Pacific Congenital Heart Disease Treatment Device Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Congenital Heart Disease Treatment Device Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Congenital Heart Disease Treatment Device Sales by Type (2016-2021e) & (K Units)
Table 79. Asia-Pacific Congenital Heart Disease Treatment Device Sales by Type (2021-2026) & (K Units)
Table 80. Asia-Pacific Congenital Heart Disease Treatment Device Sales by Application (2016-2021e) & (K Units)
Table 81. Asia-Pacific Congenital Heart Disease Treatment Device Sales by Application (2021-2026) & (K Units)
Table 82. South America Congenital Heart Disease Treatment Device Sales by Country (2016-2021e) & (K Units)
Table 83. South America Congenital Heart Disease Treatment Device Sales by Country (2021-2026) & (K Units)
Table 84. South America Congenital Heart Disease Treatment Device Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Congenital Heart Disease Treatment Device Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Congenital Heart Disease Treatment Device Sales by Type (2016-2021e) & (K Units)
Table 87. South America Congenital Heart Disease Treatment Device Sales by Type (2021-2026) & (K Units)
Table 88. South America Congenital Heart Disease Treatment Device Sales by Application (2016-2021e) & (K Units)
Table 89. South America Congenital Heart Disease Treatment Device Sales by Application (2021-2026) & (K Units)
Table 90. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Country (2016-2021e) & (K Units)
Table 91. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Country (2021-2026) & (K Units)
Table 92. Middle East & Africa Congenital Heart Disease Treatment Device Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Congenital Heart Disease Treatment Device Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Type (2016-2021e) & (K Units)
Table 95. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Type (2021-2026) & (K Units)
Table 96. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Application (2016-2021e) & (K Units)
Table 97. Middle East & Africa Congenital Heart Disease Treatment Device Sales by Application (2021-2026) & (K Units)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Congenital Heart Disease Treatment Device Typical Distributors
Table 101. Congenital Heart Disease Treatment Device Typical Customers
List of Figures
Figure 1. Congenital Heart Disease Treatment Device Picture
Figure 2. Global Congenital Heart Disease Treatment Device Sales Market Share by Type in 2020
Figure 3. Artificial Heart Valve
Figure 4. Bracket
Figure 5. Ventricular Assist Device (VAD)
Figure 6. Other
Figure 7. Global Congenital Heart Disease Treatment Device Sales Market Share by Application in 2020
Figure 8. Adult
Figure 9. Children
Figure 10. Global Congenital Heart Disease Treatment Device Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Congenital Heart Disease Treatment Device Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Congenital Heart Disease Treatment Device Sales (2016-2026) & (K Units)
Figure 13. Global Congenital Heart Disease Treatment Device Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Congenital Heart Disease Treatment Device Production Capacity (2016-2026) & (K Units)
Figure 15. Global Congenital Heart Disease Treatment Device Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Congenital Heart Disease Treatment Device Market Drivers
Figure 17. Congenital Heart Disease Treatment Device Market Restraints
Figure 18. Congenital Heart Disease Treatment Device Market Trends
Figure 19. Global Congenital Heart Disease Treatment Device Sales Market Share by Manufacturer in 2020
Figure 20. Global Congenital Heart Disease Treatment Device Revenue Market Share by Manufacturer in 2020
Figure 21. Congenital Heart Disease Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Congenital Heart Disease Treatment Device Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Congenital Heart Disease Treatment Device Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Congenital Heart Disease Treatment Device Sales Market Share by Region (2016-2026)
Figure 25. Global Congenital Heart Disease Treatment Device Revenue Market Share by Region (2016-2026)
Figure 26. North America Congenital Heart Disease Treatment Device Revenue (2016-2026) & (USD Million)
Figure 27. Europe Congenital Heart Disease Treatment Device Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Congenital Heart Disease Treatment Device Revenue (2016-2026) & (USD Million)
Figure 29. South America Congenital Heart Disease Treatment Device Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Congenital Heart Disease Treatment Device Revenue (2016-2026) & (USD Million)
Figure 31. Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2016-2026)
Figure 32. Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2016-2026)
Figure 33. Global Congenital Heart Disease Treatment Device Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2016-2026)
Figure 35. Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2016-2026)
Figure 36. Global Congenital Heart Disease Treatment Device Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Congenital Heart Disease Treatment Device Sales Market Share by Type (2016-2026)
Figure 38. North America Congenital Heart Disease Treatment Device Sales Market Share by Application (2016-2026)
Figure 39. North America Congenital Heart Disease Treatment Device Sales Market Share by Country (2016-2026)
Figure 40. North America Congenital Heart Disease Treatment Device Revenue Market Share by Country (2016-2026)
Figure 41. United States Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Congenital Heart Disease Treatment Device Sales Market Share by Type (2016-2026)
Figure 45. Europe Congenital Heart Disease Treatment Device Sales Market Share by Application (2016-2026)
Figure 46. Europe Congenital Heart Disease Treatment Device Sales Market Share by Country (2016-2026)
Figure 47. Europe Congenital Heart Disease Treatment Device Revenue Market Share by Country (2016-2026)
Figure 48. Germany Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Congenital Heart Disease Treatment Device Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Congenital Heart Disease Treatment Device Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Congenital Heart Disease Treatment Device Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Congenital Heart Disease Treatment Device Revenue Market Share by Region (2016-2026)
Figure 57. China Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Congenital Heart Disease Treatment Device Sales Market Share by Type (2016-2026)
Figure 64. South America Congenital Heart Disease Treatment Device Sales Market Share by Application (2016-2026)
Figure 65. South America Congenital Heart Disease Treatment Device Sales Market Share by Country (2016-2026)
Figure 66. South America Congenital Heart Disease Treatment Device Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Congenital Heart Disease Treatment Device Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Congenital Heart Disease Treatment Device Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Congenital Heart Disease Treatment Device Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Congenital Heart Disease Treatment Device Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Congenital Heart Disease Treatment Device Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source